MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Lunit Highlights Most Up-To-Date Research on Commercial AI Suite for Radiology at RSNA 2022

By MedImaging International staff writers
Posted on 26 Nov 2022
Print article
Image: Lunit INSIGHT CXR and Lunit INSIGHT MMG (Photo courtesy of Lunit)
Image: Lunit INSIGHT CXR and Lunit INSIGHT MMG (Photo courtesy of Lunit)

Lunit (Seoul, South Korea) is returning to the Radiological Society of North America to attend the 108th Scientific Assembly and Annual Meeting (RSNA 2022), being held from Nov. 27 – Dec. 1. The company is presenting eight abstracts highlighting its most up-to-date research on the Lunit INSIGHT suite, an AI solution for radiology.

Since 2016, the company has continued to present findings yearly at RSNA based on its most mature products for radiology - Lunit INSIGHT CXR, an AI solution for chest X-ray, and Lunit INSIGHT MMG, an AI solution for mammography. Lunit has since presented upgraded versions of the two software, now clinically available in 1,000 medical sites across more than 40 countries. Last year, Lunit also showcased a demo version of its brand-new AI solution for Digital Breast Tomosynthesis (Lunt INSIGHT DBT), signaling its expansion of the Lunit INSIGHT product line.

This year's program features seven oral presentations, including studies that aimed to evaluate the performance of Lunit's commercial AI suite for radiology across massive real-world population groups. Presentations based on Lunit INSIGHT CXR include an investigation of the clinical impact of implementing an AI CXR CAD system on the referral rate to chest CT, as well as a study aimed to evaluate the efficacy of a deep learning-based chest CT registration model for pulmonary nodule interval changes. Presentations featuring Lunit INSIGHT MMG include an evaluation of AI as an independent reader for screening mammograms, a study measuring the impact of downsampling of digital mammography images on AI cancer detection, and a study comparing the performance of the Lunit INSIGHT MMG and Lunit INSIGHT DBT.

"Lunit is proud to announce that 7 out of our 8 research studies have been selected for oral presentation at RSNA this year - a meaningful breakthrough in the academic recognition of the developing medical AI field," said Lunit CEO Brandon Suh. "We plan on utilizing this year's meeting to actively interact with our business partners and visitors."

Related Links:
Lunit 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
Acclarix AX9
PACS Workstation
CHILI Web Viewer
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more